GI Innovation, Inc. (KOSDAQ:358570)
South Korea · Delayed Price · Currency is KRW 7,890.00
-290.00 (-3.55%)
Sep 1, 2026, 3:30 PM KST
GI Innovation Market Cap
GI Innovation has a market cap or net worth of 527.74 billion as of September 1, 2026. Its market cap has decreased by -48.84% in one year.
Market Cap
527.74B
Enterprise Value
490.42B
Revenue
5.50B
Ranking
n/a
PE Ratio
n/a
Stock Price
7,890.00
ChartMarket Cap Chart
Since March 30, 2023, GI Innovation's market cap has increased from 445.59B to 527.74B, an increase of 18.44%. That is a compound annual growth rate of 5.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 31, 2026 | 527.74B | -53.14% |
| Dec 30, 2025 | 1.13T | 187.90% |
| Dec 30, 2024 | 391.21B | -26.45% |
| Dec 28, 2023 | 531.89B | 19.37% |
| Mar 30, 2023 | 445.59B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chabiotech | 754.82B |
| Pharmicell | 673.25B |
| Onconic Therapeutics | 670.67B |
| Komipharm International | 669.89B |
| Hyundai Bioscience | 631.13B |
| AbClon | 519.75B |
| Medy-Tox | 463.40B |
| GC Corp. | 460.37B |